The Pharma Letter Podcast — Episode 22 — A new way to innovate, from Flagship Pioneering
More on this story...
Today's issue
Company Spotlight
A Vancouver-based antibody discovery company that deploys high-throughput single-cell screening technology to identify and develop therapeutic antibodies across infectious disease, rare disease, and neurology.
More Features in Biotechnology
Copyright © The Pharma Letter 2026
| Headless Content Management with Blaze